The North America non-invasive aesthetic treatment market size is expected to reach USD 46.07 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028. Non-invasive aesthetic treatments are procedures that do not require surgical intervention, have minimal downtime, lower risks of complications, and lower cost of treatment. The market growth is attributed to the rising demand for fillers and injectable including Botox as a result of the increasing target population across the globe. The demand for anti-aging aesthetic solutions that are non-invasive has escalated due to the increasing geriatric population pool.
According to the American Society of Plastic Surgeons (ASPS), high growth was observed in facial rejuvenation procedures, and the number of botulinum toxin type A procedures was the highest, accounting for over 7.7 million injections (Botox, Dysport, Xeomin) in 2019. It was also noted that in 2019, around 4,73,354 botulinum toxin filler procedures were performed on men in the U.S. This indicates that demand for the procedure is rapidly increasing among men.
The U.S is among the top countries to carry out non-invasive aesthetic treatments globally as the acceptance towards advanced procedures is higher in the country. Moreover rising disposable income, superior medical infrastructure, the prevalence of skin conditions, and a large pool of aesthetic professionals are expected to boost the market growth.
In the light of COVID-19, the global non-invasive aesthetic treatment market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended. The American Society of Plastic Surgeons stated that the pandemic reduced the overall uptake of aesthetic treatments; however, it will be the reason for an upsurge in demand for cosmetic procedures in the coming years, which is expected to rise even higher than previous numbers.
Request a free sample copy or view report summary: North America Non-invasive Aesthetic Treatment Market Report
The injectable segment held the largest market share in 2020 and is also expected to show the highest CAGR over the forecast period. This is mainly due to the wide applications of aesthetic treatment
The skin rejuvenation segment held a revenue share of 24.0% in 2020 owing to advancements in procedures like photo rejuvenation, deep chemical peel, and laser resurfacing
On the basis of end-use, the Medspa segment held the largest revenue share of 34.2% in 2020 because medical esthetic centers are owned and governed by licensed physicians, surgeons, estheticians, and nurses
U.S dominated the market in 2020, owing to increasing disposable income, high expenditure on healthcare, a large pool of certified professionals, and increased prevalence of skin conditions among the population
Grand View Research has segmented the North America non-invasive aesthetic treatment market on the basis of procedure, end-use, and region:
North America Non-invasive Aesthetic Treatment Procedure Outlook (Revenue, USD Million, 2016 - 2028)
Injectables
Botulinum Toxin
Calcium Hydroxylapatite
Hyaluronic Acid
Polymer Filler
Collagen
Skin Rejuvenation
Chemical Peel
Laser Skin Resurfacing
Photo rejuvenation
Others
Hair Removal
Nonsurgical Fat Reduction
Sclerotherapy
Cellulite Treatment
North America Non-invasive Aesthetic Treatment End-use Outlook (Revenue, USD Million, 2016 - 2028)
Hospital/Surgery Center
Medspa
Traditional Spa
HCP owned clinic
North America Non-invasive Aesthetic Treatment Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
List of Key Players of North America Non-invasive Aesthetic Treatment Market
Toronto Cosmetic Clinic (TCC)
The Cosmetic Clinic
Skinovative of Gilbert-Medical Spa
Shea Aesthetic Clinic
Chapter Aesthetic Studio
AnewSkin Medspa
The Ottawa Skin Clinic
Manhattan Aesthetics
Toronto Medical Aesthetics
Dr. Cory Torgerson
Canada MedLaser, Inc
SkinRhümMD
Skin Vitality Medical Clinic
True MediSpa
Dermapure
"The quality of research they have done for us has been excellent..."